GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 ,
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial, Annals of Surgery, vol.234, issue.6, pp.758-68, 2001. ,
DOI : 10.1097/00000658-200112000-00007
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer, JAMA, vol.297, issue.3, pp.267-77, 2007. ,
DOI : 10.1001/jama.297.3.267
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection, JAMA, vol.304, issue.10, pp.1073-81, 2010. ,
DOI : 10.1001/jama.2010.1275
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer, JAMA, vol.310, issue.14, pp.1473-81, 2013. ,
DOI : 10.1001/jama.2013.279201
Rationale for En Bloc Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein Confluence, Annals of Surgery, vol.223, issue.2, pp.154-62, 1996. ,
DOI : 10.1097/00000658-199602000-00007
Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?, The American Journal of Surgery, vol.182, issue.2, pp.120-129, 2001. ,
DOI : 10.1016/S0002-9610(01)00686-9
Pancreaticoduodenectomy with Mesentericoportal Vein Resection for Adenocarcinoma of the Pancreatic Head, World Journal of Surgery, vol.7, issue.8, pp.1526-1561, 2006. ,
DOI : 10.1001/archsurg.1995.01430030065013
En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels, Annals of Surgery, vol.247, issue.2, pp.300-309, 2008. ,
DOI : 10.1097/SLA.0b013e31815aab22
Vascular Resection in Pancreatic Cancer Surgery: Survival Determinants, Journal of Gastrointestinal Surgery, vol.93, issue.10, pp.784-92, 2009. ,
DOI : 10.1016/j.ejso.2007.01.022
Vascular Reconstruction During Pancreatoduodenectomy for Ductal Adenocarcinoma of the Pancreas Improves Resectability but does not Achieve Cure, World Journal of Surgery, vol.26, issue.3, pp.2648-61, 2010. ,
DOI : 10.1016/j.jamcollsurg.2007.10.002
Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg, avr, vol.257, issue.4, pp.726-756, 2013. ,
Pancreatic Adenocarcinoma, Version 2.2014, Journal of the National Comprehensive Cancer Network, vol.12, issue.8, pp.1083-93, 2014. ,
DOI : 10.6004/jnccn.2014.0106
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS), Surgery, vol.155, issue.6, pp.977-88, 2014. ,
DOI : 10.1016/j.surg.2014.02.001
The Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct, 2010. ,
Pancreatectomy Combined with Superior Mesenteric Vein???Portal Vein Resection for Pancreatic Cancer: A Meta-analysis, World Journal of Surgery, vol.142, issue.4, pp.884-91, 2012. ,
DOI : 10.1001/archsurg.142.2.172
Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study, Journal of the American College of Surgeons, vol.218, issue.3, pp.401-412, 2014. ,
DOI : 10.1016/j.jamcollsurg.2013.11.017
Pancreaticoduodenectomy with En Bloc Portal Vein Resection for Pancreatic Carcinoma with Suspected Portal Vein Involvement, World Journal of Surgery, vol.28, issue.6, pp.602-610, 2004. ,
DOI : 10.1007/s00268-004-7250-6
Pancreaticoduodenectomy with vascular resection: margin status and survival duration, Journal of Gastrointestinal Surgery, vol.8, issue.8, pp.935-984, 2004. ,
DOI : 10.1016/j.gassur.2004.09.046
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis, European Journal of Surgical Oncology (EJSO), vol.40, issue.4, pp.371-379, 2014. ,
DOI : 10.1016/j.ejso.2014.01.010
Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma, Journal of Surgical Oncology, vol.40, issue.4, pp.414-435, 2013. ,
DOI : 10.1093/jjco/hyq011
Postoperative Morbidity and Long-term Survival After Pancreaticoduodenectomy With Superior Mesenterico???Portal Vein Resection, Journal of Gastrointestinal Surgery, vol.10, issue.8, pp.1106-1121, 2006. ,
DOI : 10.1016/j.gassur.2006.04.002
Clinical Significance of Portal-Superior Mesenteric Vein Resection in Pancreatoduodenectomy for Pancreatic Head Cancer, Pancreas, vol.41, issue.1, pp.102-108, 2012. ,
DOI : 10.1097/MPA.0b013e318221c595
Vascular invasion in pancreatic cancer: Tumor biology or tumor topography?, Surgery, vol.152, issue.3, pp.143-51, 2012. ,
DOI : 10.1016/j.surg.2012.05.012
Significance of the Depth of Portal Vein Wall Invasion After Curative Resection for Pancreatic Adenocarcinoma, Archives of Surgery, vol.142, issue.2, pp.172-181, 1960. ,
DOI : 10.1001/archsurg.142.2.172
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma, British Journal of Surgery, vol.240, issue.7, 2015. ,
DOI : 10.1097/01.sla.0000133083.54934.ae
Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer, Hepatogastroenterology. oct, vol.60, issue.127, pp.1759-65, 2013. ,
Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer, Annals of Surgery, vol.255, issue.1, pp.103-111, 2012. ,
DOI : 10.1097/SLA.0b013e318237872e
MDCT of Pancreatic Adenocarcinoma: Optimal Imaging Phases and Multiplanar Reformatted Imaging, American Journal of Roentgenology, vol.187, issue.6, pp.1513-1533, 2006. ,
DOI : 10.2214/AJR.05.1031
Staging of Pancreatic Adenocarcinoma by Imaging Studies, Clinical Gastroenterology and Hepatology, vol.6, issue.12, pp.1301-1309, 2008. ,
DOI : 10.1016/j.cgh.2008.09.014
Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?, Current Oncology Reports, vol.14, issue.4, pp.1-9, 2014. ,
DOI : 10.1097/CJI.0b013e3181eec14c
Evidence-based diagnosis and staging of pancreatic cancer, Best Practice & Research Clinical Gastroenterology, vol.20, issue.2, pp.227-51, 2006. ,
DOI : 10.1016/j.bpg.2005.10.005
Pancreatic Cancer, New England Journal of Medicine, vol.362, issue.17, pp.1605-1622, 2010. ,
DOI : 10.1056/NEJMra0901557
Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?, Annals of Surgical Oncology, vol.41, issue.4, pp.817-842, 2009. ,
DOI : 10.1007/s00268-007-9015-5
Importance of resectability status in neoadjuvant treatment for pancreatic cancer, Journal of Hepato-Biliary-Pancreatic Sciences, vol.21, issue.7, 2015. ,
DOI : 10.1002/jhbp.130
Neoadjuvant strategies for pancreatic cancer, World J Gastroenterol WJG. 28 juill, vol.20, issue.28, pp.9374-83, 2014. ,
Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies, World Journal of Gastroenterology, vol.20, issue.42, pp.15564-79, 2014. ,
DOI : 10.1002/jso.21527
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study), BMC Cancer, vol.8, issue.19, p.346, 2011. ,
DOI : 10.1186/1471-2407-8-82
Margin Clearance and Outcome in Resected Pancreatic Cancer, Journal of Clinical Oncology, vol.27, issue.17, pp.2855-62, 2009. ,
DOI : 10.1200/JCO.2008.20.5104
The Prognostic Influence of Resection Margin Clearance Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma, Journal of Gastrointestinal Surgery, vol.38, issue.3, pp.511-532, 2013. ,
DOI : 10.1016/j.ejso.2011.12.015
Most Pancreatic Cancer Resections are R1 Resections, Annals of Surgical Oncology, vol.92, issue.6, pp.1651-60, 2008. ,
DOI : 10.1007/3-540-27449-9_5
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1???mm of a resection margin, Histopathology, vol.27, issue.18 suppl (abstr, pp.277-83, 2009. ,
DOI : 10.1111/j.1365-2559.2009.03376.x
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma, British Journal of Surgery, vol.91, issue.5, pp.586-94, 2004. ,
DOI : 10.1002/bjs.4484
The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas, Virchows Archiv, vol.433, issue.3, pp.237-279, 1998. ,
DOI : 10.1007/s004280050242
Cancer du pancréas: rapport présenté au 112e Congrès français de chirurgie, Paris, 6 -8 octobre 2010, 2010. ,